KalVista Pharmaceuticals, Inc. Appoints Brian Piekos as Chief Financial Officer (CFO)
Position
Chief Financial Officer
Company
KalVista Pharmaceuticals
CambridgeBiotechnologyHealth CareresearchDescription
KalVista Pharmaceuticals, Inc. announced the appointment of Brian Piekos as Chief Financial Officer (CFO). With his extensive experience in the biopharmaceutical industry, Mr Piekos is expected to play a key role as the company prepares for the commercialization of sebetralstat, an oral, on-demand therapy for HAE.
Quick answer
KalVista Pharmaceuticals, Inc. Appoints Brian Piekos as Chief Financial Officer (CFO) (September 10, 2024). KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Financial Officer at KalVista Pharmaceuticals?
- KalVista Pharmaceuticals named Brian Piekos Chief Financial Officer, announced September 10, 2024.
- What did KalVista Pharmaceuticals announce on September 10, 2024?
- KalVista Pharmaceuticals, Inc. announced the appointment of Brian Piekos as Chief Financial Officer (CFO). With his extensive experience in the biopharmaceutical industry, Mr Piekos is expected to play a key role as the company prepares for the commercialization of sebetralstat, an oral, on-demand therapy for HAE.
- What does KalVista Pharmaceuticals do?
- KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need.
- Where is KalVista Pharmaceuticals based?
- KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Affinia Therapeutics (September 11, 2024), AAVantgarde Bio (September 9, 2024), Climb Bio, Inc. (August 26, 2024) and Solu Therapeutics (September 10, 2024) also announced leadership changes within 45 days of KalVista Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in research and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Affinia Therapeutics Appoints Rami Daoud as Chief Business and Financial Officer (September 11, 2024)
- AAVantgarde Names Jayashree Sahni as Chief Medical Officer (September 9, 2024)
- Eliem Therapeutics Appoints Brett Kaplan, M.D. as Chief Operating Officer and Nishi Rampal, M.D. as Senior Vice President, Clinical Development (August 26, 2024)
- Solu Therapeutics Appoints Sergio Santillana as Chief Medical Officer (September 10, 2024)
- CHARM Therapeutics Appoints Dr Beverley Carr as Chief Business Officer (September 10, 2024)
- QuidelOrtho Corporation Appoints Lee Bowman as Chief Human Resources Officer (September 10, 2024)
Who to call at KalVista Pharmaceuticals, and when
A new leader at KalVista Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day KalVista Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KalVista Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KalVista Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KalVista Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
KalVista Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.